 Pharmacologic induction fetal lung maturity consequences preterm birth secondary developmental abnormality due immaturity organ systems neonatal RDS common severe complication preterm delivery major emphasis prevention and/or treatment intensive research efforts preterm labor date effective method patients result preterm birth health care provider Several medications hormones endogenous surfactant production fetus administration women risk preterm incidence severity neonatal RDS primary limiting factor agents need birth hours maximum therapeutic effect obstetric health care provider identify parturients preterm intrapartum course maximum value pharmacologic agents patients labor exogenous surfactant therapy offers real low birth weight baby maximum benefit premature infant weeks gestation therapy birth first breath therapy patients intrapartum period